Complications of Laser Vitreolysis

Slides:



Advertisements
Similar presentations
0 - 0.
Advertisements

KHOZAM I, TANGUY C, COCHENER B
Process Study 24-Month Results October 1, 2008 (abridged)
Week 1.
Paul Whiting M. D. and Daniel Galat M. D
The Diabetic Retinopathy Clinical Research Network One-Year Results from a Randomized Clinical Trial Evaluating Intravitreal Ranibizumab or Saline for.
Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema: Potential impact of.
YAG capsulotomy K.P.SHANTHA SORUBARANI.
UCL Institute of Ophthalmology Department of Genetics
GH.Naderian, M.D.. Supra choroidal hemorrhage Cystoid macular edema Retinal detachment.
CATARACT SUEGRY AND DIABETES Indications of surgery: 1) Visual loss 2)Surveillance of retinopathy 3)Laser therapy.
EX-PRESS® Device in Clinical Practice New York September, 2011 Marlene R. Moster MD Professor of Ophthalmology Thomas Jefferson School of Medicine Wills.
Treatment of breaks Ioannis Giannakis 5th Sep 2007.
EYE FLOATERS ALTERNATIVE TREATMENTS AND PREVENTION SCOTT GELLER, M.D. FORT MYERS, FLORIDA.
Roy E Lehman MD*, Samuel F Fulcher MD**
DESCEMETIC DALK AND PREDESCEMETIC DALK : OUTCOMES IN 44 CASES DR. NITESH NARAYEN CORNEA AND REFRACTIVE SURGEON MAXIVISION HYDERABAD THE AUTHOR HAS NO FINANCIAL.
CATARACT Therapy. Treatment Make sure that eyeglasses or contact lenses are the most accurate prescription possible Improve the lighting in your home.
VR Disorders Retinal Detachment (RD)
Vitrectomy Outcomes in Eyes with Diabetic Macular Edema, Visual Loss, and Vitreomacular Traction Sponsored by the National Eye Institute, National Institutes.
PIGGYBACK LENS AFTER MULTIFOCAL IOL IMPLANTATION Eric C. Amesbury MD Kevin M. Miller MD The authors have no financial interest.
Clinical evaluation of foldable acrylic phakic IOL (fP) implantation ASCRS, San Diego, 2011 A.John Kanellopoulos, MD Professor NYU Medical School, NY Director,
Intraocular lens dislocation secondary to haptic torsion Lawrence E. Lohman, MD FACS Matthew C. Willett, MD.
Copyright restrictions may apply JAMA Ophthalmology Journal Club Slides: Elevated Intraocular Pressure After Intravitreal Triamcinolone Acetonide Aref.
The Diabetic Retinopathy Clinical Research Network
Copyright restrictions may apply JAMA Ophthalmology Journal Club Slides: Trabeculectomy for Open-Angle Glaucoma Takihara Y, Inatani M, Ogata-Iwao M, et.
Purpose: Introduction:  At initial evaluation: For post-op day # 0 patients: Pre-op VA was 20/50.6 (0.395 ± 0.198); Post-op VA was 20/102.0 (0.196 ± 0.162);
Laser-Ranibizumab-Triamcinolone for DME Study DRCR.net Protocol I
Retinal nerve fiber layer thickness change in patients with wet AMD treated with ranibizumab, short term results Advantages: To determine the effect of.
Beginner’s Technique with SLT
Glaucoma and Penetrating Keratoplasty : Incidence, Risk Factors, and Outcomes Sonika Gupta Consultant Ophthalmology Max Eye Care New Delhi, India Author.
Unnecessary capsulotomy due to a missed diagnosis of Vitreous opacities Scott Geller MD Fort Myers Florida.
AlphaCor TM : A Novel Approach to Minimize Late Post-operative Complications V. Ngakeng MD, M. Price PhD. MBA, F. Price MD.
A Randomized Trial of Peribulbar Triamcinolone Acetonide with and without Focal Photocoagulation for Mild Diabetic Macular Edema: A Pilot Study.
1 Clinical Outcomes of DSEK Surgery Combined With Other Intraocular Procedures Neil Mahesh Vyas, MD Fei Yu, PhD Anthony J. Aldave, MD Sophie Deng, MD,
Ruth Lapid-Gortzak MD, Jan Willem van der Linden, BOpt,
The Diabetic Retinopathy Clinical Research Network
Safety and efficacy of bromfenac ophthalmic solution 0.09% (Xibrom™) compared to prednisolone acetate 1% for treatment of ocular inflammation following.
Efficacy of Bromfenac 0.09% in Prevention and Treatment of Pseudophakic CME When Used Preoperatively and Postoperatively by Melissa M. Cable, MD, FAAO,
The authors have no financial interest in the subject matter of this poster. FINANCIAL DISCLOSURES.
Introduction  Selective Laser Trabeculoplasty (SLT) uses a Q-Switched frequency- doubled (532 nm), low energy Nd:YAG laser, which targets melanocytes.
Combined cataract surgery and endoscopic cyclophotocoagulation in patients with glaucoma without prior incisional glaucoma surgery Matthew P. Traynor,
Alexander J. Brucker, M.D. Protocol Chair
PHACO-TRAB VERSUS PHACO ONLY IN EYES WITH ADVANCED OR END-STAGE GLAUCOMA WITH CONTROLLED INTRAOCULAR PRESSURE AND VISUALLY SIGNIFICANT CATARACT Liaska.
Adriana S. Forseto1, MD Walton Nosé1,2, MD
Sponsored by the National Eye Institute,
Efficacy and Safety of the Ex-PRESS Glaucoma Mini-Shunt with Intraoperative 5-Fluorouracil ASCRS 2009 – San Francisco A. Balashanmugam, MD, L. Farrokh-Siar,
“It’s Been One Week Since You Looked at Me”: Increased IOP in Traumatic Angle Recession Without Hyphema Lisa Hwang, M.D.1 Sharmila Srinivasan, M.D.1 Jonathan.
Effect of Refractive State on Selective Laser Trabeculoplasty ASCRS 2011 Kevin Lai Stony Brook University School of Medicine Elaine M. Miglino Floral Park.
Post-Operative Management of Vitreous Adhesion after DSAEK with YAG Laser Vitreolysis Sherif Idris 1, Ahmed Al-Ghoul 2 MD FRCSC DipABO 1 University of.
4/3/2016 U F G Universidade Federal de Goiás C B C O Centro Brasileiro de Cirurgia de Olhos A Prospective, Comparative Study Between Endoscopic Cyclophotocoagulation.
Endoscopic Management of Displaced IOL Causing Recurrent Hyphema in Patient With Pseudoexfoliation J. M. Rouse, M. A. Khaimi Dean McGee Eye Institute,
Vitrase (Hyaluronidase for Injection) Advisory Committee Meeting March 17, 2003 Jennifer D. Harris, MD Medical Officer Division of Anti-inflammatory, Analgesic,
Wynnedale Medical Center LASER EYE SURGERY UNIT FIND OUT IF LASER SURGERY IS RIGHT FOR YOU.
VR Disorders Common Clinical Presentation & Retinal Detachment (RD)
Effect of Previous Argon Laser Trabeculoplasty on Selective Laser Trabeculoplasty ASCRS 2011 Lawrence F. Jindra, MD Columbia University Winthrop University.
Long-term results of Phakic Refractive Lens (PRL™) implantation in high myopic eyes. Ioannis G. Pallikaris 1, 2, MD, PhD, Maria I. Kalyvianaki 1, MD, PhD,
The Diabetic Retinopathy Clinical Research Network
Simultaneous Cataract and ECP Glaucoma Surgery An opportunity to improve your vision while reducing or completely eliminating your dependence on Glaucoma.
The Diabetic Retinopathy Clinical Research Network
Selective laser trabeculoplasty in Korean eyes with medically uncontrolled pseudoexfoliation glaucoma Su Chan Lee1, Jung Hyun Lee1,
Aliki Liaska, Dpt of Ophthalmology,
World Cornea Congress VI April 7-9, 2010
DR ANUP KUMAR LAHIRY MD;DD
Restore Your Vision With Retina Care Doctor
Protocol U Short-Term Evaluation of Combination Dexamethasone + Ranibizumab vs. Ranibizumab Alone for Persistent Central-Involved DME Following Anti-VEGF.
Comparison of the Visian Implantable Collamer Lens with the Verisyse Phakic Intraocular Lens in High Myopia Jigna Joshi MD Marian Macsai MD Parag Majmudar.
A presentation to: Meeting name Date
DRCR Retina Network Treatment for Center-Involved DME in Eyes with Good Visual Acuity (Protocol V)
Japanese Red Cross Society
ASCRS 2010 Joseph A. Donnelly Albert Einstein College of Medicine
Presentation transcript:

Complications of Laser Vitreolysis Scott Geller MD Feike Gerbrandy MD Fort Myers, Florida Amsterdam, Netherlands In spite of two decades of reports of successful outcomes for laser vitreolysis, the Ophthalmic community has been slow to adopt this treatment modality, in part due to lack of large clinical studies of complication rates. We reviewed the medical records of 3 Ophthalmologists who performed laser vitreolysis during the year 2011 on 542 eyes of 502 patients. Surgeon 1 (SG) 25 years experience LASAG Microruptor II YAG 691 sessions 219 patients 232 eyes average 4.7 mJ/pulse 435 p/session Surgeon 2 (JK) 12 years experience Ellex YAG 308 sessions 140 patients 140 eyes average 8.0 mJ/pulse 150 p/session Surgeon 3 (FG) 3 years experience Zeiss Visulase YAG 302 session 143 patients 170 eyes average 6.8 mJ/pulse 378 p/session OBSERVED COMPLICATIONS 3 eyes elevated IOP (>30) 1 phakic, 2 pseudophakic; 7050 mJ total average engergy 2 patients (1 phakic, 1 pseudophakic) returned to normal IOP after 5 months medical therapy 1 patient required cyclodialysis surgery after 2 months unsuccessful (IOP 36) medical therapy 3 eyes elevated IOP (2phakic, 1 pseudophakic), 12419 mJ total average energy 2 eyes retinal hematoma with no visual sequelae (1 eye had BRVO 3.5 months post laser) 1 eye retinal tear 2 weeks post laser 2 sessions 2729 mJ 806 pulses 1 eye presumed lens opacity unconfirmed by a second ophthalmologist CONCLUSION Experienced surgeons have a very low complication rate Retinal detachment is NOT a significant issue with laser vitreolysis Elevated intraocular pressure is a major concern, more so with high power/pulse settings in pseudophakes

Feike Gerbrandy, Amstelveen Safety of Floaterlaser or YAG vitreolysis, the learning curve of 500 eyes Complicaties van eerste 150 ogen (1) vergeleken met volgende 350 ogen(2): Groep 1: direct complications 2.6% 3x retinal hit 1x traumatic cataract late adverse events: 1x retinal detachment (0,66%), 1x elevated IOP (0,66%). Groep 2: direct complications 0% 0x retinal hit 0x traumatic cataract late adverse events: 2x retinal detachment (0,57%) 4x elevated IOP (1,14%) Conclusie: YAG vitreolysis heeft laag risico indien uitgevoerd door een ervaren oogarts. Er is een lange leercurve. Dit pleit ervoor dat floaterlaser als subspecialisme door een beperkt aantal ervaren oogartsen moet worden uitgevoerd. Oogdrukstijging staat los van ervaring. Feike Gerbrandy, Amstelveen

Feike Gerbrandy, Amsterdam Safety of Floaterlaser or YAG vitreolysis, the learning curve of 500 eyes Complicaties van eerste 150 ogen (1) vergeleken met volgende 350 ogen(2): Groep 1: direct complications 2.6% 3x retinal hit 1x traumatic cataract late adverse events: 1x retinal detachment (0,66%), 1x elevated IOP (0,66%). Groep 2: direct complications 0% 0x retinal hit 0x traumatic cataract late adverse events: 2x retinal detachment (0,57%) 4x elevated IOP (1,14%) Conclusie: YAG vitreolysis heeft laag risico indien uitgevoerd door een ervaren oogarts. Er is een lange leercurve. Dit pleit ervoor dat floaterlaser als subspecialisme door een beperkt aantal ervaren oogartsen moet worden uitgevoerd. Oogdrukstijging staat los van ervaring. Feike Gerbrandy, Amsterdam www.floaterlaser.nl

Feike Gerbrandy, Amsterdam Safety of Floaterlaser or YAG vitreolysis, the learning curve of 500 eyes Feike Gerbrandy, MD Background: Floaterlaser, YAG vitreolysis or nebulotrypsia is a laser treatment of vitreous floaters. Worldwide there are only a handfull of ophthalmologists able to perform this treatment. They founded the International Society of Vitreous Laser Surgery (ISVLS). The members of the ISVLS cooperate in research and treatment protocols. Feike Gerbrandy started doing floaterlaser in 2009. Since then he has treated about 750 eyes In a recent study by his team (submitted for publication) about 86% of patients are satisfied with the result. These data show that most disturbing floaters can be succesfully treated by laser. As with many treatments: after the pioneers have showed the way followers will come: more ophthalmologists will want to learn floaterlaser. Feike Gerbrandy, Amsterdam www.floaterlaser.nl

Feike Gerbrandy, Amsterdam Safety of Floaterlaser or YAG vitreolysis, the learning curve of 500 eyes First 500 cases were analysed for complications: First 150 eyes (group 1) were compared with following 350 (group 2): Group 1: direct complications 2.6% 3x retinal hit 1x traumatic cataract late adverse events: 1x retinal detachment (0,66%), 1x elevated IOP (0,66%). Group 2: direct complications 0% 0x retinal hit 0x traumatic cataract late adverse events: 2x retinal detachment (0,57%) 4x elevated IOP (1,14%) Feike Gerbrandy, Amsterdam www.floaterlaser.nl

Feike Gerbrandy, Amsterdam Safety of Floaterlaser or YAG vitreolysis, the learning curve of 500 eyes Evaluation: In the first 150 eyes the lens or retina was hit in 2.6% of eyes, versus 0% in the following 350 eyes. This clearly illustrates the learning curve of this technique. Conclusion: Floaterlaser of YAG vitreolysis or nebulotrypsia is a low risk and safe procedure if performed by an experienced ophthalmologist. The patient demand for this procedure is increasing. Feike Gerbrandy, Amsterdam www.floaterlaser.nl

Feike Gerbrandy, Amstelveen Floaterlaser Gerbrandy Number of eye satisfied Not satisfied Retinal detachment blind Follow up Laser 255 85.1% 14.9% 0.39% 0% 343 day 11.2 month PPV 341 88.4% 8.89% 6.16% 2.6% 550 day 18 months Feike Gerbrandy, Amstelveen

Basiscursus Floaterlaser 2013 Morgen 10.30 Zaal 1 Feike Gerbrandy Opsis Oogziekenhuis Amsterdam www.floaterlaser.nl Feike Gerbrandy, Amsterdam